270 related articles for article (PubMed ID: 27474439)
1. Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase.
Yang S; Zheng X; Lu C; Li GM; Allis CD; Li H
Genes Dev; 2016 Jul; 30(14):1611-6. PubMed ID: 27474439
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for the role of oncogenic histone mutations in modulating H3K36 methylation.
Zhang Y; Shan CM; Wang J; Bao K; Tong L; Jia S
Sci Rep; 2017 Mar; 7():43906. PubMed ID: 28256625
[TBL] [Abstract][Full Text] [Related]
3. Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.
Rajagopalan KN; Chen X; Weinberg DN; Chen H; Majewski J; Allis CD; Lu C
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619101
[TBL] [Abstract][Full Text] [Related]
4. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
Lu C; Jain SU; Hoelper D; Bechet D; Molden RC; Ran L; Murphy D; Venneti S; Hameed M; Pawel BR; Wunder JS; Dickson BC; Lundgren SM; Jani KS; De Jay N; Papillon-Cavanagh S; Andrulis IL; Sawyer SL; Grynspan D; Turcotte RE; Nadaf J; Fahiminiyah S; Muir TW; Majewski J; Thompson CB; Chi P; Garcia BA; Allis CD; Jabado N; Lewis PW
Science; 2016 May; 352(6287):844-9. PubMed ID: 27174990
[TBL] [Abstract][Full Text] [Related]
5. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
[TBL] [Abstract][Full Text] [Related]
6. The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas.
Fang D; Gan H; Lee JH; Han J; Wang Z; Riester SM; Jin L; Chen J; Zhou H; Wang J; Zhang H; Yang N; Bradley EW; Ho TH; Rubin BP; Bridge JA; Thibodeau SN; Ordog T; Chen Y; van Wijnen AJ; Oliveira AM; Xu RM; Westendorf JJ; Zhang Z
Science; 2016 Jun; 352(6291):1344-8. PubMed ID: 27229140
[TBL] [Abstract][Full Text] [Related]
7. Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase.
Qian C; Wang X; Manzur K; Sachchidanand ; Farooq A; Zeng L; Wang R; Zhou MM
J Mol Biol; 2006 May; 359(1):86-96. PubMed ID: 16603186
[TBL] [Abstract][Full Text] [Related]
8. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
Berthelet J; Michail C; Bui LC; Le Coadou L; Sirri V; Wang L; Dulphy N; Dupret JM; Chomienne C; Guidez F; Rodrigues-Lima F
Mol Pharmacol; 2021 Sep; 100(3):283-294. PubMed ID: 34266924
[TBL] [Abstract][Full Text] [Related]
9. The N-terminus of Drosophila SU(VAR)3-9 mediates dimerization and regulates its methyltransferase activity.
Eskeland R; Czermin B; Boeke J; Bonaldi T; Regula JT; Imhof A
Biochemistry; 2004 Mar; 43(12):3740-9. PubMed ID: 15035645
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase.
Couture JF; Collazo E; Brunzelle JS; Trievel RC
Genes Dev; 2005 Jun; 19(12):1455-65. PubMed ID: 15933070
[TBL] [Abstract][Full Text] [Related]
11. Cryo-EM structure of SETD2/Set2 methyltransferase bound to a nucleosome containing oncohistone mutations.
Liu Y; Zhang Y; Xue H; Cao M; Bai G; Mu Z; Yao Y; Sun S; Fang D; Huang J
Cell Discov; 2021 May; 7(1):32. PubMed ID: 33972509
[TBL] [Abstract][Full Text] [Related]
12. SET domain protein lysine methyltransferases: Structure, specificity and catalysis.
Qian C; Zhou MM
Cell Mol Life Sci; 2006 Dec; 63(23):2755-63. PubMed ID: 17013555
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants for α-tubulin methylation by SETD2.
Kearns S; Mason FM; Rathmell WK; Park IY; Walker C; Verhey KJ; Cianfrocco MA
J Biol Chem; 2021 Jul; 297(1):100898. PubMed ID: 34157286
[TBL] [Abstract][Full Text] [Related]
14. SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing.
Zhu K; Lei PJ; Ju LG; Wang X; Huang K; Yang B; Shao C; Zhu Y; Wei G; Fu XD; Li L; Wu M
Nucleic Acids Res; 2017 Jan; 45(1):92-105. PubMed ID: 27614073
[TBL] [Abstract][Full Text] [Related]
15. Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2.
Eram MS; Kuznetsova E; Li F; Lima-Fernandes E; Kennedy S; Chau I; Arrowsmith CH; Schapira M; Vedadi M
Biochim Biophys Acta; 2015 Sep; 1850(9):1842-8. PubMed ID: 26002201
[TBL] [Abstract][Full Text] [Related]
16. The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation.
Qiao Q; Li Y; Chen Z; Wang M; Reinberg D; Xu RM
J Biol Chem; 2011 Mar; 286(10):8361-8368. PubMed ID: 21196496
[TBL] [Abstract][Full Text] [Related]
17. S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3.
Jayaram H; Hoelper D; Jain SU; Cantone N; Lundgren SM; Poy F; Allis CD; Cummings R; Bellon S; Lewis PW
Proc Natl Acad Sci U S A; 2016 May; 113(22):6182-7. PubMed ID: 27185940
[TBL] [Abstract][Full Text] [Related]
18. Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3-MutSα interaction.
Fang J; Huang Y; Mao G; Yang S; Rennert G; Gu L; Li H; Li GM
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9598-9603. PubMed ID: 30181289
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the histone methyltransferase PRDM9 using biochemical, biophysical and chemical biology techniques.
Koh-Stenta X; Joy J; Poulsen A; Li R; Tan Y; Shim Y; Min JH; Wu L; Ngo A; Peng J; Seetoh WG; Cao J; Wee JL; Kwek PZ; Hung A; Lakshmanan U; Flotow H; Guccione E; Hill J
Biochem J; 2014 Jul; 461(2):323-34. PubMed ID: 24785241
[TBL] [Abstract][Full Text] [Related]
20. Preparation, Biochemical Analysis, and Structure Determination of SET Domain Histone Methyltransferases.
Bergamin E; Couture JF
Methods Enzymol; 2016; 573():209-40. PubMed ID: 27372755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
